key: cord-0970782-rv0jd7h0 authors: Afrad, Mokibul Hassan; Khan, Manjur Hossain; Rahman, Sadia Isfat Ara; Bin Manjur, Omar Hamza; Hossain, Mohabbat; Alam, Ahmed Nawsher; Khan, Farzana Islam; Afreen, Nawroz; Haque, Farsim Tarannum; Thomson, Nicholas R.; Shirin, Tahmina; Qadri, Firdausi title: Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh date: 2021-07-15 journal: Microbiology resource announcements DOI: 10.1128/mra.00560-21 sha: d18a97cc9c81c9e354556fb73bed94994702f0c2 doc_id: 970782 cord_uid: rv0jd7h0 We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network. . However, the rate of confirmed SARS-CoV-2 cases nationwide gradually decreased to less than 10% (SARS-CoV-2 test positivity rate) in mid-May 2021. Recently (third week of May 2021), there was a substantial increase in the COVID-19 detection rate in the bordering districts (Chapainawabgonj, Khulna, and Satkhira) in the northwestern part of Bangladesh. We investigated whether this sudden increase was due to SARS-CoV-2 variants that might have been imported into Bangladesh through population movement in the Bangladesh-India border regions. We obtained the SARS-CoV-2-positive samples (n = 15) through the nationwide COVID-19 surveillance network maintained by the Institute of Epidemiology, Disease Control, and Research (IEDCR), a mandated institute for disease outbreak investigation and response in Bangladesh. This genomic surveillance is an ongoing activity that was approved by the institutional review board of the IEDCR (protocol IEDCR/IRB/2020/11). These 15 samples include samples from (i) randomly selected SARS-CoV-2-positive community patients (n = 7) with COVID-19 symptoms who were residing in the border district of Chapainawabgonj and (ii) Bangladeshi individuals (n = 8) with a history of recent travel to India who were found to be SARS-CoV-2 positive by reverse transcriptase (RT) PCR, irrespective of COVID-19 symptom appearance (3). The patients' ages ranged from 13 to 52 years; four of the patients were asymptomatic, while others presented mild to moderate symptoms. Except for one individual, none had been vaccinated prior to infection. Viral RNA was extracted from nasopharyngeal swab samples using the QIAamp viral RNA minikit (Qiagen). Sequencing libraries were prepared using the multiplex PCR amplicon sequencing approach developed by the ARTIC Network (4, 5) . Libraries were multiplexed and sequenced on a FLO-MIN106D (R9.5) flow cell for at least 12 h. Raw reads were base called and demultiplexed with MinKNOW v21.02.1. Processed reads were assembled using the ARTIC guppyplex script with Medaka v1.4 using the ARTIC EPI2ME v3.3.0 SARS-CoV-2 pipeline (FastQ quality control plus ARTIC plus NextClade) (https://artic.network/ncov-2019/ncov2019-bioinformatics-sop.html). In total, 4,324,431 reads were obtained (range, 79,314 to 734,341 reads per sample; average length, 507 bp). Table 1 summarizes the information for each sample. Nucleotide variations were confirmed by visual inspection using CLC Genomics Workbench v21.0 (Qiagen). Compared to the reference Wuhan Hu-1 genome, a set of 10 amino acid substitutions (shared among all 15 strains) was identified, including the five signature amino acid changes (T19R, L452R, T478K, P681R, and D950N) in the spike protein corresponding to the genetic markers of sublineage B.1.617.2. Sequences were aligned using MAFFT v7.4 (6) . A phylogenetic tree (Fig. 1) was constructed with IQ-TREE v2 (7) with an ultrafast bootstrap value of 1,000 (8) and with the GTR1F1I model selected as the best-fit model by the IQ-TREE Web server (9) and was visualized using FigTree v1.4 (10) . Phylogenetic analysis with Pangolin (github.com/cov -lineages/pangolin) assigned 15 samples to clade G, lineage B.1.617.2. Here, we report the early detection of SARS-CoV-2 delta variant B.1.617.2 in the Bangladeshi community, which will be useful toward mitigation of a possible third wave of COVID-19 in Bangladesh, as has been seen elsewhere. Data availability. The data from this study can be found under GISAID accession numbers EPI_ISL_1938477, EPI_ISL_2105565, EPI_ISL_2180455, EPI_ISL_2284894, EPI_ISL_2284885, EPI_ISL_2284886, EPI_ISL_2284887, EPI_ISL_2304461, EPI_ISL_2304462, EPI_ISL_2284888, EPI_ISL_2304463, EPI_ISL_2284890, EPI_ISL_2284891, EPI_ISL_2284892, and EPI_ISL_2284893. The Sequence Read Archive (SRA) and GenBank accession numbers are listed in Table 1 . COVID-19 Bangladesh situation report-66 COVID-19 rise in Bangladesh correlates with increasing detection of B.1.351 variant Chinese Center for Disease Control and Prevention. 2020. Laboratory testing for COVID-19. Chinese Center for Disease Control and Prevention nCoV-2019 sequencing protocol v3 (LoCost) Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using aLeaves facilitates ondemand exploration of metazoan gene family trees on MAFFT sequence alignment server with enhanced interactivity IQ-TREE: a fast and effective stochastic algorithm for estimating maximum likelihood phylogenies UFBoot2: improving the ultrafast bootstrap approximation ModelFinder: fast model selection for accurate phylogenetic estimates FigTree: tree figure drawing tool, v1.4.2. University of Edinburgh The Bill and Melinda Gates Foundation funded the study. The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) acknowledges with gratitude the commitment of the Bill and Melinda Gates Foundation to its research efforts. icddr,b is grateful to the governments of Bangladesh, Canada, Sweden, and the United Kingdom for providing core/unrestricted support.We acknowledge physicians and diagnostic testing staff members at the IEDCR and the Institute for Developing Science and Health Initiatives who provided initial diagnostic testing of the SARS-CoV-2 samples.